Morgan Stanley Bio Techne Corp Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
A detailed history of Morgan Stanley transactions in Bio Techne Corp stock. As of the latest transaction made, Morgan Stanley holds 7,237,878 shares of TECH stock, worth $430 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,237,878
Previous 6,578,943
10.02%
Holding current value
$430 Million
Previous $338 Million
18.95%
% of portfolio
0.03%
Previous 0.02%
Shares
25 transactions
Others Institutions Holding TECH
# of Institutions
646Shares Held
162MCall Options Held
514KPut Options Held
347K-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.06 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$890 Million0.02% of portfolio
-
State Street Corp Boston, MA5.75MShares$342 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.12MShares$304 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA4.93MShares$293 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.33B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...